Reference Studies:

Is it possible that mainstream medicine got cholesterol all wrong? That not only does cholesterol have no connection to heart disease, but that high cholesterol is actually a good thing?
Yes, it’s more than possible - here I’ll show some evidence that higher cholesterol is associated with longer life.

All-cause mortality vs heart disease
Obviously, people die from many causes, whether natural, such as heart disease, cancer, or infection, or unnatural, such as from homicide, suicide, or accidents.

Should we be concerned about what cause we die from?
Yes, and no.
On the one hand, if you’re dead, you’re dead, no matter from what. On the other, dying in your sleep in old age may be preferable to a long, lingering illness.
Nevertheless, from a public health standpoint, it seems a mistake to focus on changing something that lowers the risk of death from one cause only to raise that risk from another.

While total cholesterol is a poor if not utterly worthless risk marker for heart disease, doctors have focused on it to the exclusion of how it might affect other causes of death. It does you little good to save yourself from heart disease if it means that you increase your risk of death from cancer.

All-cause mortality - death from anything - is the most appropriate measure to use when looking at risk factors.

Older people with higher cholesterol live longer
Population studies in Japan show that people of all ages with higher cholesterol live longer.1

Overall, an inverse trend is found [in Japan] between all-cause mortality and total (or low density lipoprotein [LDL]) cholesterol levels: mortality is highest in the lowest cholesterol group without exception.  If limited to elderly people, this trend is universal.  As discussed in Section 2, elderly people with the highest cholesterol levels have the highest survival rates irrespective of where they live in the world.
Consider the chart above, taken from the paper.  It shows all-cause mortality by cholesterol levels, men on the left, women on the right.
Current guidelines call for keeping cholesterol at 200 mg/dl or lower, yet higher levels meant lower death rates.
What about outside Japan?  The following chart shows cumulative all-cause mortality of people older than 85 in Leiden, The Netherlands, by cholesterol level.
The cohort with an average cholesterol of 252 mg/dl, the highest, had the lowest death rates.
The following shows data from elderly people in Finland.  Those with cholesterol greater than 232 mg/dl had the lowest death rates.
The data from Japan is for all ages; the data from outside Japan is for the elderly.
What about the data for all ages, outside of Japan?
The authors believe that the presence of people with familial hypercholesterolemia, which causes a very high cholesterol level and which raises the risk of death, in the highest cholesterol categories, accounts for higher death rates in those categories.
They also argue that cholesterol levels in that disorder are not the cause of increased death rates.
A recent review in the prominent medical journal BMJ regarding LDL cholesterol, the risk marker considered most significant, found either no association or an inverse association between LDL and death rates.

High LDL-C is inversely associated with mortality in most people over 60 years.  This finding is inconsistent with the cholesterol hypothesis (ie, that cholesterol, particularly LDL-C, is inherently atherogenic).  Since elderly people with high LDL-C live as long or longer than those with low LDL-C, our analysis provides reason to question the validity of the cholesterol hypothesis. 
Moreover, our study provides the rationale for a re-evaluation of guidelines recommending pharmacological reduction of LDL-C in the elderly as a component of cardiovascular disease prevention strategies.

The Honolulu Heart Program was one of the first studies to find this inverse relation between total cholesterol and death rates in elderly people, aged 71 to 93.  It found that compared to the lowest quartile (fourth) of cholesterol level, increasing quartiles of cholesterol had cholesterol had 28%, 40%, and 35% decreased death rates, respectively.
Furthermore, the Honolulu study seems to provide evidence that actually raising cholesterol is protective, since
“Only the group with low cholesterol concentration at both examinations had a significant association with mortality.”
The authors of the study concluded, “We have been unable to explain our results. These data cast doubt on the scientific justification for lowering cholesterol to very low concentrations (<4.65 mmol/L) [<180 mg/dl] in elderly people.”
Is high cholesterol protective?
Why would people with low cholesterol die at higher rates than those with higher cholesterol?

Several things could be going on.
Cholesterol may protect against infections and atherosclerosis.
Cholesterol may protect against cancer.
A strong association was found between low cholesterol and violence. Odds ratio of violence for cholesterol of <180 mg/dl was 15.49.
Several studies have found an association between low cholesterol and suicide.  For instance, one study found that those in the lowest quartile (fourth) of cholesterol concentration had more than 6 times the risk of suicide as those in the highest quartile.

A number of studies have found that, at least in people older than 60, high cholesterol is associated with lower death rates.
This fact casts considerable doubt on the cholesterol hypothesis of heart disease.
Why, with so much evidence against it, does the cholesterol theory still have so much traction? To quote the authors in the first cited study, it’s all about the money:

We believe the answer is very simple: for the side defending this so-called cholesterol theory, the amount of money at stake is too much to lose the fight.

Update: I hadn’t seen this before I wrote this article, but Uffe Ravnskov, a co-author of some of the above-cited studies, has a good article with many relevant citations, The Benefits of High Cholesterol.
PS: For more on how to live longer, see my books, Stop the Clock andMuscle Up.

    Ann Nutr Metab 2015;66(suppl 4):1-116 DOI: 10.1159/000381654
    Ravnskov, Uffe, et al. “Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review.” BMJ open 6.6 (2016): e010401.
    Ravnskov, Uffe. “High cholesterol may protect against infections and atherosclerosis.” Qjm96.12 (2003): 927-934.
    Ravnskov, U., K. S. McCully, and P. J. Rosch. “The statin-low cholesterol-cancer conundrum.”QJM (2011): hcr243.
    Mufti, Rizwan M., Richard Balon, and Cynthia L. Arfken. “Low cholesterol and violence.”Psychiatric services (2006).
    Ellison, Larry F., and Howard I. Morrison. “Low serum cholesterol concentration and risk of suicide.” Epidemiology 12.2 (2001): 168-172.

Almost everybody today believes that high cholesterol is the main cause of heart disease & heart attacks.
                    However, there have been several studies done in recent years that show JUST THE OPPOSITE!

Of course, there is a great deal of $$ being made by prescribing & selling all the anti-cholesterol drugs on the market - BILLION$$$$
So, it is NO WONDER that most doctors, and certainly most People, are not aware of this.

Following are some Reference Articles and STUDIES that explain these findings:
Reference the Articles below:

Higher Cholesterol Is Associated With Longer Life
P. D. Mangan
People with high cholesterol live the longest
Posted on 12/27/2015 by Uffe Ravnskov

This statement seems so incredible that it takes a long time to clear one´s brainwashed mind to fully understand its importance.
Yet the fact that
people with high cholesterol live the longest emerges clearly from many scientific papers.1
But let us take a look at heart mortality,the risk of dying from a heart attack if cholesterol is high.

Consider for instance the finding by Dr.Harlan Krumholz of the Department of Cardiovascular Medicine at Yale University, who reported that old people with low cholesterol died twice as often from a heart attack as did old people with high cholesterol.2 Supporters of the cholesterol campaign consistently ignore his observation, or consider it as a rare exception, the result of chance among a huge number of studies finding the opposite.

But it is not an exception; there are now a large number of findings that contradict the lipid hypothesis. To be more specific, almost all studies of old people have shown that high cholesterol is not a risk fact for coronary heart disease. This was the result of my search in the Medline database for studies addressing that question.3 Eleven studies of old people came up with that result, and a further seven found that high cholesterol did not predict all-cause mortality either, and more such studies have been published since then.

I have mentioned it before, but it is worth repeating, that more than 90 percent of those who die from a heart attack or a stroke have passed the age of 65. You may also recall that high cholesterol is not a risk factor for women, nor for a number of other population groups.

But there is more comfort for those who have high cholesterol. At least fifteen studies have found that total mortality is inversely associated with either total or LDL-cholesterol, or both. This means that it is actually much better to have high than to have low cholesterol if you want to be very old.

Many studies have found that low cholesterol in certain respects is worse than high cholesterol. For instance, in nineteen large studies of more than 68,000 deaths, reviewed by David R. Jacobs and his co-workers from the Division of Epidemiologyat the University of Minnesota, low cholesterol predicted an increased risk of dying from gastrointestinal and respiratory diseases.4 Most gastrointestinal and respiratory diseases have an infectious origin.
Therefore, a relevant question is whether it is the infection that lowers cholesterol or the low cholesterol that predisposes to infection? You have probably already guessed what the directors of the cholesterol campaign have said, but is it true?

To answer that question David Jacobs´ group followed more than 100,000 healthy individuals in the San Francisco area for fifteen years. At the end of the study those who had low cholesterol at the start of the study had been admitted more often to hospital because of an infectious disease of the respiratory system or because of another type of infection.5,6  This finding cannot be explained away with the argument that the infection had caused cholesterol to go down, because how could low cholesterol be caused by a disease they had not yet encountered? Isn´t it much more likely that low cholesterol in some way made them more vulnerable to infection, or that high cholesterol protected those who did not become infected? Much evidence exists to support that interpretation.

Young, unmarried men with a previous sexually transmitted disease or liver disease run a much greater risk of becoming infected with HIV virus than other people.7
Similar results came from a study of the MRFIT screenees. Sixteen years later four times more among those with the lowest cholesterol had died from AIDS compared with those who had the highest.8

Heart disease may lead to a weakening of the heart muscle. A weak heart means that less blood and therefore less oxygen is delivered to the arteries. To compensate for the decreased power, the heart beat goes up, but in severe heart failure this is not sufficient. Such patients become short of breath because too little oxygen is delivered to the tissues, the pressure in their veins increases because the heart cannot deliver the blood away from the heart with sufficient power, and they become edematous, meaning that fluid accumulates in the legs and in serious cases also in the lungs and other parts of the body. This condition is called congestive or chronic heart failure.

There are many indications that bacteria or other microorganisms play an important role in chronic heart failure, and also that the risk of heart failure is much greater in people with low cholesterol.9-13

Furthermore, children born with very high cholesterol, so-called familial hypercholesterolemia, are protected against infection. But if inborn high cholesterol protects against infections, inborn low cholesterol should have the opposite effect. Indeed, this seems to be true.

Children with the Smith-Lemli-Opitz syndrome have very low cholesterol because the enzyme that is necessary for the last step in the body’s synthesis of cholesterol does not function properly. Most children with this syndrome are either stillborn or they die early because of serious malformations of the brain .Those who survive are imbecile, they have extremely low cholesterol, and they suffer from frequent and severe infections. However, if their diet is supplemented with pure cholesterol or extra eggs, their cholesterol goes up and their bouts of infection become less serious and less frequent.14

There is no contradictory observation that can´t be explained away by the believers. One of the most striking aberrations appeared in two recent studies from the US. The first one came from the medical departmentat the University of California in LA.15   A total of 137,000 patients from 541 hospitals in the US had been admitted because of an acute heart attack.  In all of them, their cholesterol was analysed within the first 24 hours of admission.  To their surprise, the authors found that their cholesterol was lower than normal. To be precise, their mean total cholesterol was 174 (4.46 mmol/l) and the ‘bad’ LDL cholesterol was also much lower than normal.

It is not possible to explain away the result by using the argument that it was a result of chance, considering that this is the largest study of the cholesterol levels of heart patients, which has ever been published. The researchers were of course surprised. One explanation could be the well-known fact that cholesterol goes down in patients with an acute myocardial infarction, but they rejected it, because this happens first after two-three days and the reduction is only fifteen percent at most.16,17

Did the authors, three of whom were supported by eight drug companies, realize that they had stumbled upon something important? That high cholesterol may not be the cause of heart disease?
Of course not. What they concluded was that cholesterol must be reduced even further.

A few months later a research group from Henry Ford Heart and Vascular Institute in Detroit came up with a similar result.18  Again, LDL cholesterol measured within the first 24 hours of admission was lower than normal, not higher. To be precise, in half of the 500 patients LDL-cholesterol was lower than 105 (2.69 mmol/l).  They thought that something had gone wrong and were convinced that those whose LDL was below 105 had a much better chance to survive than those whose LDL was higher, because this is what all of us have been told by the American Heart Association and the drug companies repeatedly.

Three years later it appeared that among those with the lowest LDL-cholesterol  twenty-six patients had died, but only twelve among those with the highest LDL-cholesterol. The authors considered their finding very salient. They warned their readers against feeling a false sense of security in patients with low LDL. Although more of those with low LDL were on statin treatment, they wrote , ”these patients may in fact need more aggressive risk modification.”

Recently I published a paper together with 15 international colleagues, where we reviewed 19 studies of elderly people (>60 years) who had been followed for several years.  None of these studies found that LDL-cholesterol (the “bad” one) predisposes to cardiovascular disease; on the contrary, most of them showed that those with high LDL cholesterol lived the longest.19

There is a logical explanation.  What very few know is that LDL, the molecule that transport cholesterol in the blood, partake in the immune system by adhering to and inactivating all kinds of miocroorganisms and their toxic products.  You can read more about that in two papers that I have published together with Kilmer McCully, he who discovered the association between homocystein and atherosclerosis.20,21


Kozarevic D et al. Serumcholesterol and mortality: the Yugoslavia Cardiovascular Disease Study.Am J Epidemiol. 1981Jul;114(1):21-8.
Rudman D et al. Antecedentsof death in the men of a Veterans Administration nursing home. J Am Geriatr Soc. 1987 Jun;35(6):496-502.
Forette B et al. Cholesterol as risk factor for mortality in elderly women.Lancet. 1989;22;1:868-70.
Staessen J et al. Is a high serum cholesterol level associated with longersurvival in elderly hypertensives? J Hypertens. 1990;8(8):755-61.
Salonen JT et al. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 1991;84:129-39.
Harris T et al. The low cholesterol-mortality association in a national cohort. J Clin Epidemiol. 1992;45(6):595-601.
Zimetbaum et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly: The Bronx Aging Study. Arterioscler Thromb 1992;12:416-23.
Casiglia E et al. Predictorsof mortality in very old subjects aged 80 years or over.
EurJ Epidemiol. 1993;9(6):577-86.
Kronmal RA et al. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med 1993;153:1065-73.
Krumholz HM et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 1994;272(17):1335-40.
Jonsson A et al. Total cholesterol and mortality after age 80 years. Lancet. 1997;350(9093):1778-9
Räihä I et al. Effectof serum lipids, lipoproteins, and apolipoproteins on vascular and nonvascularmortality in the elderly. Arterioscler Thromb Vasc Biol. 1997;17(7):1224-32.
Behar S et al. Low total cholesterol is associated with high total mortality in patients with coronary heart disease. Eur Heart J. 1997;18(1):52-9.
Fried LP et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279(8):585-92.
Chyou PH, Eaker ED. Serum cholesterol concentrations and all-cause mortality in older people. Age Ageing. 2000;29(1):69-74.
Schatz IJ et al. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet. 2001;358(9279):351-5.
Weverling-Rijnsburger AW et al. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary arterydisease and stroke in old age. Arch Intern Med. 2003;163:1549-54.
Onder G et al. Serum cholesterol levels and in-hospital mortality in the elderly. Am J Med. 2003;115(4):265-71.
Casiglia E et al. Total cholesterol and mortality in the elderly. J Intern Med. 2003;254:353-62.
Psaty BM et al.  The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study.J Am Geriatr Soc. 2004 Oct;52(10):1639-47.
Ulmer H et al. Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. J Womens Health 2004;13(1):41-53.
Schupf N et al. Relationship between plasma lipids and all-cause mortality in non demented elderly. J Am Geriatr Soc. 2005;53(2):219-26.
Tikhonoff V et al. Low-density lipoprotein cholesterol and mortality in older people. J Amer Geriatr Soc 2005;53:2159-64.
Sritara P et al. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study. Angiology 2007;58:757-63.
Åkerblom JL et al. Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing. 2008;37:207-13.
Noda H et al. Gender difference of association between LDL cholesterol concentrations and mortality from coronary heart disease amongst Japanese: the Ibaraki Prefectural Health Study. J Intern Med 2010;267:576- 87
Newson RS et al. Association between serum cholesterol and noncardiovascular mortality in older age. J Am Geriatr Soc.2011;59:1779-85.
Krumholz HM et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years..272, 1335-40, 1994.
Ravnskov U. High cholesterol may protect against infections and atherosclerosis. 96, 927-934, 2003.
Jacobs D et al. Report ofthe Conference on Low Blood Cholesterol: MortalityAssociations.  Circulation 86, 1046-60, 1992
Iribarren C  et al. Serum total cholesterol and risk of hospitalization, and death from respiratory disease  J Epidemiol 26, 1191-202, 1997.
Iribarren C et al. Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases. Epidemiol Infect 121, 335-47, 1998.
Claxton AJ et al.  Association between serum total cholesterol and HIV infection in a high-risk cohort of young men. J Acquir Immune Defic Syndr Hum Retrovirol 17, 51-7, 1998.
Neaton JD, Wentworth DN. Endotoxin and immune activation in chronic heart failure: a prospective cohort study AIDS 11,929-30, 1997.
Rauchhaus M et al. The endotoxin-lipoprotein hypothesis Lancet 356, 930-3, 2000.
NiebauerJ er al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study Lancet 353, 1838-1842, 1999.
Vredevoe DL et al. Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 82, 323-8, 1998.
Rauchhaus M et al.  The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42, 1933-40, 2003.
Kalantar-Zadeh K et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure J Am Coll Cardiol 43, 1439-44, 2004.
Elias ER et al. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS) Am J Med Genet 68, 305-10, 1997.
Sachdeva A et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J 2009;157:111-7.
Gore JM et al. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol 1984;54:722-5.
Sewdarsen M et al. Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction Postgrad Med J 1988;64;352-6.
Al-Mallah MH et al. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction Cardiol J 2009;16:227-33
Ravnskov U et al. . Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review BMJ Open 2016;6(6):e010401
Ravnskov U, McCully KS. Vulnerable plaque formation from obstruction of vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies. Ann Clin Lab Sci 2009;39:3-16.
Ravnskov U, McCully KS. Infections may be causal in the pathogenesis of atherosclerosis. Am J Med Sci. 2012;344(5):391-4.

About Uffe Ravnskov 
I am an independent medical researcher      (click this link to see all below - it has the LINKS to everything)
About myself
Uffe Ravnskov, MD, PhDBorn 1934 in Copenhagen, Denmark.
Graduated 1961 from the University of Copenhagen with an MD.
1961-1967 various appointments at surgical, roentgenological, neurological, pediatric and medical departments in Denmark and Sweden.
1968-79 various appointments at the Department of Nephrology, and the Department of Clinical Chemistry, University Hospital, Lund, Sweden; 1975-79 as an assistant professor at the Department of Nephrology.
1973 PhD at the University of Lund. A specialist in internal medicine and nephrology.
1979-2000 a private practitioner. Since 1979 an independent researcher.
Honoured by the Skrabanek Award 1999 given by Trinity College of Dublin, Ireland for original contributions in the field of medical scepticism
Honoured by the 2007 Leo-Huss-Walin Prize for Independent Thinking in Natural Sciences and Medicine.
Member of International Science Oversight Board
Director of THINCS, The International Network of Cholesterol Skeptics

My books
A selection of my newsletters.
Talk given in Sydney 2006 (Audio)
Talk given in Copenhagen 2010 (Youtube eight parts in Danish)
Interview May 2011; OneRadioNetwork
Talk in Oslo 2013
Interview (in Danish) 2014

Reviews of my first book The Cholesterol Myths:
Stephen Byrnes, PhD, ND, RNCP
Michael Gurr, PhD, Professor
Joel Kauffman, Research Professor
Ira Pilgrim, PhD
Ray Rosenman, MD
Cuttings from amazon and Barnes & Nobles reviews
Tom Naughton
John Brignell, PhD, Professor

Papers and books published in English about cardiovascular issues
Most papers are readable. Just click on the title.
Some of them show the first page only. If so, click on the arrow in the lower, left corner to continue.

Ravnskov U. Aneurysm of the heart and the post-myocardial-infarction syndrome. Acta Med Scand 1968;183:393-5
Ravnskov U. Fluctuating pericardial effusion. N Engl J Med 1969;281:854
Ravnskov, U. Lowering cholesterol concentrations and mortality. BMJ 1990;301: 814.
Ravnskov U. An elevated serum cholesterol is secondary, not causal, in coronary heart disease. Medical Hypotheses 1991;36:238-41.
Ravnskov U. Atherogenicity and thrombogenicity indices. Lancet 338, 1328, 1991.
Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1992;305: 15-19. Letters: BMJ 1992;305:420-422, and 717.
Ravnskov U. The fragile links of the diet-heart chain. Nutrition Quarterly 1992;16:19-21.
Ravnskov U. Cardiovascular disease in developing countries. BMJ 1993;306:145-6.
Ravnskov U. Dietary fats and blood lipids as cardiovascular risk factors in the general population. A critical overview. Proceedings of the I. World Congress of Dairy Products in Human Health and Nutrition. Madrid 1993. Rotterdam: Balkema 1994, p 361-369.
Ravnskov U. Reducing serum cholesterol. Lower cholesterol of doubtful benefit to anyone. BMJ 1993;307:125.
Ravnskov U. Coronary atherosclerosis on angiography-progress or regress and why? Circulation 1993;88:1358-9.
Ravnskov U. Hypercholesterolemia does not cause coronary heart disease - evidence from the nephrotic syndrome. Nephron 1994;66:356-7.
Ravnskov U. Ischaemic heart disease and cholesterol. Optimism about drug treatment is unjustified. BMJ 1994;308:1038.
Ravnskov U. Is there a cause-effect relationship between high blood cholesterol and atherosclerosis? Workshop on cholesterol-lowering trials. National Heart, Lung and Blood Institute, Bethesda 1994.
Ravnskov U. What do angiographic changes after cholesterol lowering mean? Lancet 1994;344:1297.
Ravnskov U. Is intake of trans-fatty acids and saturated fat causal in coronary heart disease? Circulation 1994;90:2568-9.
Ravnskov U. Doing the right thing: stop worrying about cholesterol. Circulation 1994;90:2572-3.
Ravnskov U. Quotation bias in reviews of the diet-heart idea. J Clin Epidemiol 1995;48:713-719.
Ravnskov U. Implications of 4S evidence on baseline lipid levels. Lancet 1995;346:181.
Ravnskov U. Beneficial effects of simvastatin may be due to non-lipid actions. BMJ 1995;311:1436-1437.
Ravnskov U. The American College of Physicians guidelines on cholesterol screening. Ann Intern Med 1996; 125:1010-1011.
Ravnskov U. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol 1998;51:443-460. Read also a dissent to the paper: Golomb BA. Dietary fats and heart disease-dogma challenged? and my answer; same journal and same issue. This paper won the Skrabanek Award 1999
Ravnskov U. Why heart disease mortality is low in France. Author´s hypothesis is wrong. BMJ 1999;319:255
Ravnskov U. VAT and fat. Evidence is contradictory. BMJ 2000;320:1470
Ravnskov U. Prevention of atherosclerosis in children. Lancet 2000;355:69.
Ravnskov U. The Cholesterol Myths. Washington: New Trends Publishing, 2000;
Ravnskov U. Cholesterol and all-cause mortality in Honolulu. Lancet 2001; 358: 1907.
Ravnskov U. Diet-heart disease hypothesis is wishful thinking. BMJ 2002; 324: 238
Ravnskov U, Allan C, Atrens D, Enig MG, Groves B, Kaufman J, Kroneld R, Rosch P, Rosenman R, Werkö L, Nielsen JV, Wilske J, Worm N. Studies of dietary fat and heart disease. Science 2002; 295: 1464-5.
Ravnskov U. Statins as the new Aspirin. Conclusions from the heart protection study were premature. BMJ 2002;324:789.
Ravnskov U. Is atherosclerosis caused by high cholesterol? QJM 2002; 95: 397-403. This paper was also selected for publication in the third issue of South African Excerpts Edition of the QJM 2002.
Ravnskov U. A hypothesis out-of-date: The diet-heart idea. J Clin Epidemiol, 2002;55:1057-63. Same issue: Dissent by W.S. Weintraub and Reply by U. Ravnskov
Ravnskov U. ASCOTT-LLA: Questions about the benefits of atorvastatin. Lancet 2003;361:1986.
Ravnskov U. Lipoproteins and cardiovascular risk. Lancet 2003;361:1988-1989.
Ravnskov U. The retreat of the diet-heart hypothesis. J Amer Phys Surg. 2003;8:no 3, 94-95
Ravnskov U. High cholesterol may protect against infections and atherosclerosis. QJM 2003;96:927-34
Ravnskov U. Dietary fat intake and risk of stroke. BMJ 2003;327:1348
Ravnskov U. Inflammation, Cholesterol Levels, and Risk of Mortality Among Patients Receiving Dialysis. JAMA 2004;291:1833-1834.
Ravnskov U, Sutter MC. Aggressive lipid-lowering therapy and regression of coronary atheroma. JAMA. 2004;292:38
Ravnskov U, Rosch P, Sutter MC. Intensive lipid-lowering with atorvastatin in coronary disease. N Engl J Med 2005;353:94.
Ravnskov U. Dietary fat is not the villain. BMJ 2005;331:906-7.
Ravnskov U, Rosch PJ, Sutter MC, Houston MC. Should we lower cholesterol as much as possible? BMJ 2006;332:1330-1332.
Ravnskov U, Rosch PJ, Sutter MC. High-Dose Statins and the IDEAL Study. JAMA 2006;295:2476. In their response the authors did not give us the requested information.
Ravnskov U. Saturated fat does not affect blood cholesterol Am J Clin Nutr 2006;84:1550-51. Read also Martijn B Katans response as well as a discussion about our correspondence by Michael R Eades and others.
Ravnskov U. Lack of Evidence for Recommended Low-Density Lipoprotein Cholesterol Treatment Targets. Ann Intern Med 2007;146:614.
Ravnskov U. Cholesterol lowering and mortality: A sea of contradictions.Nutr Metab Cardiovasc Dis. 2007;17:e25-7
Accurso A et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metabol 2008;5:9
Ravnskov U. Re: The Association Between Statins and Cancer Incidence in a Veterans Population.J Ntl Cancer Inst 2008; doi: 10.1093/jnci/djn160
Ravnskov U. Should medical science ignore the past? BMJ 2008;337:a1681
Ravnskov U. The fallacies of the lipid hypothesis. Scand Cardiovasc J 2008;42-236-239
Ravnskov U, McCully KM. Vulnerable plaque formation from obstruction of vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies. Ann Clin Lab Sci 2009;39:3-16
Ravnskov U. Fat and Cholesterol are GOOD for You. GB Publishing 2009.
Ravnskov U. Cholesterol was healthy in the end. World Rev Nutr Diet 2009;100:90-109.
Ravnskov U. Is saturated fat bad? In: Modern Dietary fat intakes in disease promotion. Nutr Health 2010, part 2, p 109-119
Ravnskov U. Ignore the Awkward! How the Cholesterol Myths Are Kept Alive. Createspace 2010
Ravnskov U. The doubtful associaton between blood lipid changes and progression of atherosclerosis. Int J Cardiol 2011;153:95
Ravnskov U. Questionable long-term benefits in the UK ASCOT-LLA trial Eur Heart J 2011
Ravnskov U. Rosch PJ, McCully KS. The statin-low cholesterol-cancer conundrum. QJM doi:10.1093/qjmed/hcr243
Ravnskov U, McCully KS. Infections may be causal in the pathogenesis of atherosclerosis. Am J Med Sci 2012
Ravnskov U, Rosch PJ, McCully KS. Re: Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials. BMJ Rapid response 8. Dec 2011
Ravnskov U, Diamond D, Karatay MC, Miller DW, Okuyama H. No scientific support for liunking dietary saturated fat to CHD. Br J Nutr 2012;107:455-457.
Ravnskov U. More discrepancies around saturated fat and cardiovasdular diseases. Nutrition 2012;28:713.
Ravnskov U, McCully KS. How macrophages are converted to foam cells. J Atheroscl Thromb (E-pub ahead of print)
Ravnskov U, Diamond D, Karatay MC, Miller DW, Okuyama H. No scientific support for linking dietary saturated fat to CHD. Br J Nutr. 2012;107:455-7.
Ravnskov U, McCully KS, Infections may be causal in the pathogenesis of atherosclerosis. 2013. A short version of our previous paper (reference 59)
Ravnskov U, DiNicolantonio JJ, Harcombe Z, Kummerow FA, Okuyama H, Worm N. The questionable benefits of exchanging saturated fat with polyunsaturated fat. Mayo Clin Proc 2014;89:451-3. A short video presentation
Ravnskov U. Lack of evidence that saturated fat causes cardiovascular disease. BMJ 2014;348:g320
Ravnskov U, McCully KS. Biofilms, lipoprotein aggregates, homocysteine, and arterial plaque rupture. MBio. 2014;5(5):e01717-14.
Ravnskov U, Rosch PJ, McCully KS. Statins do not protect against cancer: quite the opposite. J Clin Oncol. 2015;33:810-1. doi: 10.1200/JCO.2014.58.9564.
Diamond DM, Ravnskov U. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharmacol. 2015;8:201-10. A comment to our paper and our response.
Ravnskov U, Okuyama H, Harcombe Z. Association of specific dietary fats with mortality. JAMA Intern Med. 2016;176(12):1878. doi: 10.1001/jamainternmed.2016.7125.
Ravnskov U, Diamond DM, Hama R, Hamazaki T, Hammarskjöld B, Hynes N, Kendrick M, Langsjoen PH, Malhotra A, Mascitelli L, McCully KS, Ogushi Y, Okuyama H, Rosch PJ, Schersten T, Sultan S, Sundberg R. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review.BMJ Open. 2016 Jun 12;6(6):e010401
Ravnskov U. Comment on ‘Statin use and all-cancer survival: prospective results from the Women’s Health Initiative‘. Br J Cancer 2017. doi: 10.1038/bjc.2017.41
Ravnskov U, Okuyama H, Sultan S. Serious bias in 20 year follow-up study of statin trial. BMJ. 2017 Oct 31;359:j4906. doi: 10.1136/bmj.j4906.
Ravnskov U, de Lorgeril M, Diamond DM, Hama R, Hamazaki T, Hammarskjöld B, Hynes N, Kendrick M, Langsjoen PH, Mascitelli L, McCully KS, Okuyama H, Rosch PJ, Schersten T, Sultan S, Sundberg R. LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature. Expert Rev Clin Pharmacol. 2018 Oct;11(10):959-970. doi: 10.1080/17512433.2018.1519391
Ravnskov U, de Lorgeril M, Kendrick M, Diamond DM.Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia. Med Hypotheses. 2018 Dec;121:60-63. doi: 10.1016/j.mehy.2018.09.019.

Papers and books in other languages about cardiovascular issues
Ravnskov U. Är fleromättat fett nyttigt? Läkartidningen 1991;88:1058
Ravnskov U. Kolesterolmyten (The Cholesterol Myth). Stockholm : Streifferts, 1991; ISBN 91-7886-085-7.
Ravnskov U. Kolesteroli. Helsinki : Art House, 1992 (Finnish translation of Kolesterolmyten); ISBN 951-884-078-4.
Ravnskov U. Kolesterolmyten. Månedsskrift for praktisk Lægegerning 1991;70:131-138
Ravnskov U. Hvad er det rigtige svar i kolesteroldebatten? Ugeskrift for Læger 1992;154:1716
Ravnskov U. Kolesterol och hälsa: En titt under mattan. Livsmedelsteknik1992;4:7-8.
Ravnskov U. Tveksamheter om kolesterol. Suomen Lääkarilehti 1993;48:1063-1064.
Ravnskov U. Flera tveksamheter om kolesterol. Suomen Lääkarilehti 1993;48:1716-1717.
Ravnskov U. Tvivlsomme råd om kolesterolscreening hos børn. Ugeskrift for Læger 1993;155:1886-1887.
Ravnskov U. Nya tongånger från USA. Kolesterolkampanjen ifrågasättas. Läkartidningen 1993;90:2528-2529.
Ravnskov U. Stoppa kolesterolkampanjen! Läkartidningen 1993;90:4587-4588.
Ravnskov U. Slutreplik om kolesterol. Läkartidningen 1994;91:117-118
Ravnskov U. Livet forkortes når kolesterolet sænkes. Ugeskrift for Læger 1993;155:3678-3679.
Ravnskov U. Kolesterolsænkende lægemidler. Ugeskrift for Læger 1994;156:329
Ravnskov U. Ukritisk referat af kolesterolartikler. Ugeskrift for Læger 1994;156:4479
Ravnskov U. Fedtsyrer og forvirrende signaler. Ugeskrift for Læger 1995;157:1534-1535.
Ravnskov U. Keys eller kaos. Ugeskrift for Læger 1995;157:3210
Ravnskov U. Är fleromättat fett en orsak till manlig sterilitet? Läkartidningen 1996;93:2040
Ravnskov U. Auktoriteter kräver tolkningsföreträde. Läkartidningen 1997;95:1024-1025.
Ravnskov U. Myten om det mättade och det fleromättade fettet. Tidskriften Medikament 1998;3(4):44-51 och 1998;3(5):48-53
Ravnskov U. “Medelhavsdietens” förträfflighet är en myt. Läkartidningen 1998;95:4749-4750.
Ravnskov U. Är motion överlägsen statinbehandling? Läkartidningen 2000;97:2177
Ravnskov U. Varför blir kranskärl aterosklerotiska? Läkartidningen 2000; 98: 41
Ravnskov U. Nya intressanta fakta i Science och BMJ…Synen på matens fett håller på att förändras..Medikament 2001:5
Ravnskov U. Statinbehandling vid akut hjärtinfarkt väl optimistiskt refererat i massmedierna. Läkartidningen 2001;98:2370
Ravnskov U. Koständringar förebygger inte hjärtinfarkt. Läkartidningen 2001;98:3926
Ravnskov U. Transfettsyra-den verkliga kostboven vid hjärtinfarkt? Läkartidningen 2001;98:4060.
Ravnskov U. Amerikansk kolesterol-policy kan leda till sjukförklaring av miljontals friska. Läkartidningen 2001;98:4574-4577.
Ravnskov U. Lipidsänkning påverkar inte utvecklingen av ateroskleros vid benartärsjukdom. Läkartidningen 2001;98:4897-4898.
Nilsson, P, Ravnskov U. Brevväxling. Tidskriften Medikament 2002; 1:26-27
Ravnskov U. Överoptimistiskt referat av ny statinstudie. Läkartidningen 2002;99:949-950
Ravnskov U. Ju färre måltider desto högre kolesterol. Läkartidningen 2002;99:1356.
Ravnskov U. Surrogatforskning om hjärtsjukdom och riskfaktorer. Läkartidningen 2002;99:1507
Ravnskov U. Debatt i Science: Kostråd mot hjärtinfarkt försvaras med felcitat. Läkartidningen 2002;99:2673.
Ravnskov U, Pollmer, U. Mythos Cholesterin. Die zehn größten Irrtümer. Stuttgart: Hirzel Verlag 2002. ISBN 3-7776-1181-6
Ravnskov U. Kan brist på omega-3-fettsyror orsaka plötslig hjärtdöd? Läkartidningen 2002;99:3860
Ravnskov U. Den tveksamma nyttan av att stämma i bäcken. Tidskriften Medikament 2002; 8: 68-72 (pdf skickas på begäran)
Ravnskov U. LDL-kolesterol eller C-reaktivt protein - vilken riskfaktor väger tyngst? Läkartidningen 2003;100:696
Ravnskov U. Statiner ökar risken för cancer hos äldre. Läkartidningen 2003;100:974
Ravnskov U. Man blir inte fet av fett utan av för många kalorier och för lite motion. Läkartidningen 2003;100:3255-3256
Ravnskov U. Ingen vinst sänka kolesterolet så mycket som möjligt Läkartidningen 2004;101:549
Ravnskov U. Högt kolesterol skyddar mot infektioner och troligen även mot åderförkalkning. Läkartidningen 2004;101:1215-1217.
Ravnskov U. Kolesterolkampanjens tysta reträtt. Tidskriften Medikament 2004;9:18-20.
Ravnskov U. Vilse i pannkaken - älsklingshypotes om kolesterol. I B. Johansson (edit): Forskare klargör. Myter om maten, p. 89-96. FORMAS, Stockholm 2004.
Ravnskov U. Forhastede konklusioner om hjertedødeligheden i Norge. Tidsskr Nor Lægeforen 2004;124: 2153.
Ravnskov U. Karl Popper og kolesterolhypotesen. Tidsskr Nor Lægeforen 2004;124:2517
Ravnskov U. Mjölk ökar inte risken för hjärtkärlsjukdom. Läkartidningen 2005;102:2463
Ravnskov U. Bör kolesterolet sänkas mera effektivt? Läkartidningen 2005;102:2583.
Ravnskov U. Livsmedelsverket saknar evidens för sina kostråd. Dagens Medicin 9. november 2005
Ravnskov U. Vem bedrar vem i fetmadebatten? Medicinsk Access 2006;(1):55-56.
Ravnskov U. Kommentar till The Women’s Health Initiative Randomized Trial. 2000-talets Vetenskap. 8 Feb. 2006.
Ravnskov U. Missvisande råd om kolesterolsänkning. Läkartidningen 2006;103:568
Ravnskov U. Behandling af hyperkolesterolæmi - lower is not better. Ugeskrift for Læger 2006;168(17):1665
Ravnskov U. Åderförkalkning beror inte på obalans i apolipoproteinerna. Läkartidningen 2006;103:e35-36
Ravnskov U. Riskabelt att sänka kolesterolet så mycket som möjligt. Läkemedelsvärlden Nr 9, 2006.
Ravnskov U. Mer kritisk syn på medicinnyheter efterlyses. Dagens Medicin 6. september 2006
Ravnskov U. Kolhydratsnål kost minskar behovet av statinbehandling Läkartidningen 2006;103:3017-18
Ravnskov U. Är det vettigt att rekommendera kolhydrater till diabetiker? Medicinsk Access 2006; 7/8:80-81
Ravnskov U. Kolhydratfattig eller fettfattig kost vid fetma för diabetiker? Läkartidningen 2006;103:3071
Ravnskov U. Riskabelt att sänka kolesterolet så mycket som möjligt. Läkemedelsvärlden 30 aug 2006
Ravnskov U. Ovetenskapligt när röstning avgör kostråd. Dagens Medicin 10. oktober 2007
Ravnskov U. Vissa forskare vägrar släppa sina hypoteser. Dagens Medicin 27. februari 2008
Ravnskov U. Fett och kolesterol är hälsosamt! Optimal Förlag, Stockholm 2008. Recension (på sidan 63)
Ravnskov U. Kolesterol - myter og realiteter. Forlaget Hovedland, Højbjerg, Danmark 2008.
Ravnskov U. Finns det anledning att ta kolesterolkampanjen på allvar? Läkartidningen 2009;106:67-68 Den mest lästa artkel i Läkartidningen under året 2009
Ravnskov U, McCully Kilmer S..Den vulnerabla plaque är en böld.Medicinsk Access 2009;2:15-18.
Ravnskov U och andra. Livsmedelsverket bör sluta med kostråd till allmänheten. Dagens Medicin 8. april 2009
Ravnskov U. Nytt ljus över familjär hyperkolesterolämi. Medicinsk Access 2009;4/5:23-24.
Ravnskov U och andra. Var finns Livsmedelsverkets expertis när den behövs bäst? Dagens Medicin 3. juni 2009
Ravnskov U. Alla är olika - även metabolt. Dagens Medicin 26. juni 2009
Ravnskov U. Naukowe Klamstwo. Publisher: Wydawnictwo WGP, Warszawa 2009.
Ravnskov U. Läkarna - “nickedockor” som följer felaktiga råd om statinbehandling. Dagens Medicin 20. jan 2010
Ravnskov U. Statininducerede muskelproblemer er undervurderede. Ugeskrift for Læger 2010;172:1235
Ravnskov U. Hur kolesterolmyten hålls vid liv. Pagina. Stockholm 2010
Ravnskov U. Ännu en myt - det “hjärtvänliga” Becel. Dagens Medicin 12. maj 2010.
Ravnskov U. Många tveksamheter kring SBU’s kostråd för diabetiker. Dagens Medicin 22. juni 2010.
Ravnskov U. SBU missar poängen. Dagens Medicin 8. juli 2010.
Ravnskov U. WHO’s experter har ignorerat riskerna med fleromättat fett. Dagens Medicin 4. Oktober 2010
Ravnskov U. Vetenskap på villovägar. Dagens Medicin 26. Oktober 2010
Ravnskov U. Feiten en fabels over cholesterolen cholesterolverlagende medicijnen. Onthullingen over het grootste medische en commerciëlebedrog van deze tijd.Succesboeken, The Netherlands 2011.
Ravnskov U, Arfors KE, Enkvist C, Scherstén T, Sundberg R, Vesti Nielsen J. Ett statinpiller för mycket. Läkartidningen 2011
Ravnskov U, Jonsson BH. Riskerne med en fettrik diet är överdrivna. Läkartidningen 2012;109:486-487
Ravnskov U. Statinbehandlingens Zombie Science. Medicinsk Acces 2012;6:20-2.
Ravnskov U. Prova LCHF-diet före operation. Dagens Medicin 17. Jan. 2013
Ravnskov U. Åderförkalkning - en evig gåta. Läkartidningen 2013;110:CMLA
Ravnskov U. Cancerpatienter bør ikke behandles med statiner. Ugeskr Læger 2013;175:76
Ravnskov U, Hammarskjöld B, Sundberg R, Scherstén T. Kolesterolhypotesen måste vara fel. Läkartidningen 2016;113:D6L7

Newspaper articles
Ravnskov U. Kolesterol är ofarligt. Dagens Nyheter (Stockholm) 2. februari 1990.
Ravnskov U. De äter världens fetaste mat - utan att få hjärtinfarkt. Land (Stockholm) 12. juli 1991
Ravnskov U. Fedtkampanjen - humor eller kvaksalveri? Information (Copenhagen) 2. maj 1992.
Ravnskov U. Goddag kolesterol - økseskaft. Information (Copenhagen) 17. juni 1992.
Ravnskov U. Fortsat kolesterolgalskab. Information (Copenhagen) 26. juni 1992
Ravnskov U. Ny hjärtmedicin ger cancer, Dagens Nyheter (Stockholm) 22. april 1997
Ravnskov U. Ingen risk med fett. Dagens Nyheter (Stockholm) 7. juli 1997
Ravnskov U. Livsmedelsverkets råd saknar vetenskapligt stöd. Sundsvalls Tidning 15. juni 2005
Ravnskov U. Hur ungt är dit hjärta? Nya Åland 31. augusti 2008
Ravnskov U. Kolesteroldebat kan redde menneskeliv. Jyllandsposten 29. oktober 2008
Ravnskov U. Skrämselpropaganda av amatörer. Aftonbladet 27. januari 2009
Ravnskov U. Kolesterolmyten - en medicinsk skandal. Nya Wermlandstidningen 20. oktober 2010
Ravnskov U. Moderne diabetesbehandling er en skandale. Politiken 7. december 2010
Ravnskov U, Arfors KE, Enkvist C, Hammarskiöld B, Persson T, Scherstén T, Sundberg R, Vesti Nielsen J. Så blir åldersdiabetiker friska utan medicinering. Dagens Nyheter 27. December 2010
Ravnskov U. Hjärtprofessor sågar sig själv. Nya Åland 14. April 2011
Ravnskov U og andre. Högt kolesterol är ofarligt för kvinnor och friska män. Dagens Nyheter 26. april 2011
Ravnskov U og andre. 13 professorer og 3 docenter förvängar fakta om statiner.Dagens Nyheter 4 maj 2011
Ravnskov U, Arfors K, Enkvist C, Petersson G, Scherstén T, Sundberg R, Vesti Nielsen, J. Lita inte på myndigheternas kostråd. Kristianstadsbladet 19. Aug. 2011. Även publicerad i Sundsvalls Tidning, Borås Tidning. Livsmedelsverkets svar
Ravnskov U, Arfors K, Enkvist C, Petersson G, Scherstén T, Sundberg R, Vesti Nielsen, J Livsmedelsverket är åter på villovägar Kristianstadsbladet 30. Aug 2011. Livsmedelsverkets svar
Ravnskov U, Arfors K, Enkvist C, Petersson G, Scherstén T, Sundberg R, Vesti Nielsen, J. (Vårt svar till Livsmedelsverket). Njut av feta mejeriprodukter. Kristianstadsbladet 7. Sept 2011
Ravnskov U. Fedt er fedt. Berlingske Tidende 22 okt. 2011
Ravnskov U, Arfors KE, Enkvist C, Persson T, Schersten T, Sundberg R, VestiNielsen J. Statiner gör mer skada än nyttta. Uppsala Nya Tidning 6. feb. 2012
Ravnskov U. Naivt om kolesterol och statiner. Östersundsposten 18. april 2013
Scherstén T, Arfors K, Ravnskov U, Sundberg R. Tro ersättar vetande i hetsig LCHF-debatt. Göteborgsposten 12. aug 2013
Ravnskov U. Fett är inte problemet. Sydsvenska Dagbladet 6.Mars 2014
Ravnskov U, Schersten T, Arfors K, Sundberg R- Sluta behandla friska - satsa på de sjuka.. Göteborgs Posten 26. oktober 2014
Ravnskov U, Schersten T, Arfors K, Sundberg R. Bara ett automatsvar i kolesteroldebatten. Göteborgs Posten 13. November

Publications on the web
Ravnskov U. Questionable effects of cholesterol lowering by dietary change BMJ 15. april 1999
Ravnskov U. A stillborn hypothesis BMJ 4. jun 1999
Ravnskov U. Fiscal prevention of ischaemic heart disease should be based on facts BMJ 4. feb 2000
Ravnskov U. Plant sterols: unproved effects on health 13. April 2000
Ravnskov U. Fat myths and cardiovascular disease BMJ. 30 Mar 2001
Ravnskov U. Evidence that a high cholesterol does not cause atherosclerosis BMJ. 28 Apr 2001
Ravnskov U. New guidelines for converting healthy people into patients. BMJ 28. May 2001
Ravnskov U. The side effects from the cholesterol lowering drugs may offset their benefit. BMJ. 19 Aug 2001
Ravnskov U.The diet-heart idea: wishful thinking, impossible to refute. BMJ.28 Oct 2001
Ravnskov U. Premature conclusions from the Heart Protection Study. BMJ. 16 Nov 2001
Ravnskov U. Non-dietary factors explain the lower cholesterol concentration associated with frequent eating BMJ. 16 Jan 2002
Ravnskov U. How to mislead in preventive medicine. BMJ. 4 Feb 2002
Ravnskov U. Hypercholesterolaemia - the superior winner BMJ 16. feb 2002
Ravnskov U. Chance of surviving with and without treatment 2002 BMJ 17 Jun 2002
Ravnskov U. Association does not prove causation and is not the same as a dose-response relation. BMJ 15 Jul 2002
Ravnskov U. Statins And Cancer: Cause For Concern BMJ. 21 Oct 2002
Ravnskov U. Questionable benefit from polypill treatment. BMJ. 13 Jul 2003
Ravnskov U. Teleoanalysis - a misleading term BMJ. 15 Sept 2003
Ravnskov U. Unfounded allegations about dietary fat .BMJ. 5 Oct 2003
Ravnskov U. Serum choleterol - a surogate outcome. BMJ 6 Oct2003
Ravnskov U. The diet-heart idea is kept alive by selective citation BMJ. 8 Dec 2003
Ravnskov U. Missing figures from the INTERHEART study BMJ. 14 Oct 2004
Ravnskov U. Dietary fat is not the villain. BMJ 26. July 2005
Ravnskov U. Unsupported guidelines BMJ 9 sep 2006
Ravnskov U. Lowest possible statin dose better than a low LDL cholesterol. Ann Intern Med 17. Oct 2006
Ravnskov U. Further evidence that higher statin doses are ineffective BMJ 19. Oct 2006
Ravnskov U. Beware of the carbs! BMJ 8. Dec 2006
Ravnskov U. Should women be offered statin treatment? Certainly not! BMJ 11. may 2007
Ravnskov U. Should medical science ignore the past? BMJ 7.sept, 2008
Ravnskov U. The benefits of familial hypercholesterolaemia BMJ Oct 4, 2008
Ravnskov U., Kendrick M, Rosch PJ. Is statin treatment effective in familial hypercholesterolaemia? BMJ Nov 24, 2008
Ravnskov U. The risks of statins are underestimated. BMJ 4. juli 2009
Ravnskov U, Schersten T, Sundberg R.Doubtful effect of cholesterol lowering BMJ 30. Sep 2009
Ravnskov U, McCully KS Infections, lipoproteins and homocysteine in vascular disease 20. oct 2010
Ravnskov U, McCully KS. Inflammation, infection and cardiovascular disease 1. Mar 2011
Ravnskov U, McCully KS. Inflammation, infection and cardiovascular disease 1. Mar 2011
Ravnskov U. Saturated fat is good for you!
Ravnskov U, McCully KS, Rosch PJ. Statins,cholesterol levels, and the risk of infections. BMJ 8 Dec 2011
Ravnskov U. Rapid Response to Ebrahim et al. BMJ 27. jan. 2014
Ravnskov U. Rapid Response to Micha et al. Lack of evidence that saturated fat causes cardiovascular disease. BMJ 14. may 2014.

A selection of publications about other issues
A popular-scientific review of my research on glomerulonephritis is available

Johansson BG, Ravnskov U. The serum level and urinary excretion of 2 -microglobulin, beta2 -microglobulin and lysozyme in renal disease. Scand J Urol Nephrol. 1972;6:249-56
Lindholm T, Ravnskov U. Bacteriuria and pyuria-is it harmful? Läkartidningen 1972:69:3538-41
Hegedüs V, Ravnskov U. Cortical volume in apparently normal kidneys. Scand J Urol Nephrol. 1972;6(2):159-65
Ravnskov U, Johansson BG, Göthlin J. Renal extraction of beta2-microglobulin. Scand J Clin Lab Invest. 1972 Sep;30(1):71-5
Ravnskov U. Muramidase and acute rejections of kidney grafts. Lancet 1972;2:716
Ravnskov U. Uremic polyneuropathic motor paralysis and immobilization hypercalcemia. Scand J Urol Nephrol 1973;7:63-7
Ravnskov U. Urinary tract infection with disappearance of urinary creatinine. Case Report. Scand J Urol Nephrol 1973;7:94-5.
Ravnskov U. Albuminuria in acute and chronic renal failure. Acta Med Scand 1973;1-2(1):59-64
Ravnskov U. Proteinuria after human renal transplantation. I. Urinary excretion of alpha-2-microglobulin (retinol-binding protein), beta-2-microglobulin, lysozyme and albumin. Scand J Urol Nephrol 1974;8:37-44
Ravnskov U. Proteinuria after human renal transplantation. II. A functional identification of two types of rejection crisis.Scand J Urol Nephrol 1974;8:45-9
Krogh P, Axelsen NH, Elling F, Gyrd-Hansen N, Hald B, Hyldgaard-Jensen J, Larsen AE, Madsen A, Mortensen HP, Moller T, Petersen OK, Ravnskov U, Rostgaard M, Aalund O. Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feed. Acta Pathol Microbiol Scand Suppl. 1974;0(Suppl 246):1-21
Ravnskov U. On renal handling of plasma proteins. Scand J Urol Nephrol 1973;7 suppl 20. [Thesis]
Ravnskov U, Johansson BG, Ljunger L. Proteinuria in pigs with experimentally induced renal damage. Contributions to Nephrology 1975;1:50-61.
Ravnskov U, Karatson A. Renal handling of human ß2-microglobulin in the rat: The importance of sham-operation. Acta Physiol Scand 1975;94:467-471.
Ravnskov U. Low molecular weight proteinuria in association with paroxysmal myoglobinuria. Clinical Nephrology 1975;3:65-69
Ravnskov U. Long term prgnosis in urinary tract infections and asymptomatic bacteriuria. Läkartidningen 1975;72:1796-98.
Ekman R, Johansson BG, Ravnskov U. Gel chromatography on Sephadex gels with narrow particle size distribution obtained by dry elutriation. Anal Biochem. 1976 Feb;70(2):628-31
Ravnskov U. Serum beta2-micrglbulin and glomerular function. N Engl J Med 1976;294:611
Ekman R, Johansson BG, Ravnskov U. Renal handling of Zn alfa2-glycoprotein as compared with that of albumin and the retinol-binding protein. J Clin Invest 1976;57:945-954.
Eksmyr R, Fex G, Jagell S, Johansson BG, Ravnskov U, Samuelson G. Low molecular weight proteinuria and slight hyperlipoproteinemia in three mentally retarded brothers. Acta Paediatr Scand. 1976 Jul;65(4):521-5
Krogh P, Elling F, Gyrd-Hansen N, Hald B, Larsen AE, Lillehoj EB, Madsen A, Mortensen HP, Ravnskov U.Experimental porcine nephropathy: changes of renal function and structure perorally induced by crystalline ochratoxin A. Acta Pathol Microbiol Scand A. 1976 Sep;84(5):429-34
Ravnskov U, Johansson BG. Isolation and partial characterization of a porcine low molecular weight protein occurring in plasma and urine. Internat J Biochem 1976;7:579-583.
Svensson L, Ravnskov U. alpha1-Microglobulin, a new low molecular weight plasma protein. Clin Chim Acta 1976;73:415-22.
Ravnskov U, Dahlbäck O, Messeter L. Treatment of glomerulonephritis with drainage of the thoracic duct and plasmapheresis. Acta Med Scand 1977;202:489-94.
Ravnskov U.Exposure to organic solvents-a missing link in poststreptococcal glomerulonephritis? Acta Med Scand 1978;203: 351-356.
Ravnskov U, Forsberg B, Skerfving S. Glomerulonephritis and exposure to organic solvents. A case-control study. Acta Med Scand 1979; 205:575-579.
Ravnskov U. Acute glomerulonephritis and exposure to organic solvents in father and daughter. Acta Med Scand 1979;205:581-2
Ravnskov U, Forsberg B. Improvement of glomerulonephritis afte discontinuation of solvent exposure.Lancet 1979;1:1194
Krogh P, Elling F, Friis C, Hald B, Larsen AE, Lillehøj EB, Madsen A, Mortensen HP, Rasmussen F, Ravnskov U. Porcine nephropathy induced by long-term ingestion of ochratoxin A. Vet Pathol 1979;16:466-75
Hultberg B, Ravnskov U. The excretion of N-acetyl-ß-glucosaminidase in glomerulonephritis. Clinical Nephrology 1981;15:33-38
Ravnskov U, Lundström S, Nordén Å. Hydrocarbon exposure and glomerulonephritis: evidence from patients’ occupations. Lancet 1983;2:1214-16.
Ravnskov U. Soap is the major cause of dysuria. Lancet 1984;1:1027-8.
Ravnskov U. Hydrocarbon exposure and glomerulonephritis. Nephron 1984;36:143
Ravnskov U. Possible mechanisms of hydrocarbon-associated glomerulonephritis.. Clin Nephrol 1985;23:294-298.
Ravnskov U. Influence of hydrocarbon exposure on the course of glomerulonephritis. Nephron 1986;42:156-160.
Ravnskov U. Single-dose treatment of uncomplicated cystitis and asymptomatic bacteriuria-a review. Läkartidningen 1986;83:45-7.
Ravnskov U. Glomerulonephritis and organic solvents. Läkartidningen 1986;83:1080-1.
Ravnskov U. Focal glomerular lesions in glomerulonephritis may be secondary to tubulointerstitial damage. Am J Kidney Dis 1988; 12:250-251.
Ravnskov U. Focal, segmental glomerulosclerosis in acute renal failure. N Engl J Med 1989;320:1218.
Ravnskov U. The Chinese Mädchenfanger method as he best way of repositioning wrist. Läkaridningen 1989;86:3068-9
Ravnskov U. Non-systemic glomerulonephritis: Exposure to nephro- and immunotoxic chemicals is primary and predisposes to immunologic harassment. Medical Hypotheses 30, 115-122, 1989.
Ravnskov U. Glomerulonephritis, renal carcinoma, and solvent exposure: bias from choice of referents. Br J Indust Med 1990;47:791-2.
Ravnskov U. Hydrocarbons and renal failure: primary damage in glomerulonephr

anderson logo
Let's Restore The CONSTITUTION
Let's Return EDUCATION to parents & teachers
Let's Restore INTEGRITY to Government
Site Tree
Let's put The People back In-Charge
Click on anything BLUE & Underlined to see or download it.
Put your cursor on an Image - if it changes to a           click it.